LPL Financial’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
DSCM
LPL Financial's FLGT Position: Q2 2024 in Review
LPL Financial sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 16,289 shares — an estimated $353K sold.
LPL Financial first reported a position in FLGT in Q1 2020 and held it in 17 quarters. The position peaked at $5.45M in Q1 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.
- LPL Financial reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
- LPL Financial sold 16,289 Fulgent Genetics shares in Q2 2024, an estimated $353K.
- LPL Financial first reported a position in Fulgent Genetics in Q1 2020 and held it in 17 quarters.
- LPL Financial's Fulgent Genetics position peaked at $5.45M in Q1 2021.
- 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.
Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.